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Résumé en
anglais
BACKGROUND: Head-to-head comparisons of combinations of more than one non-
opioid analgesic (NOA) with morphine alone, for postoperative analgesia, are
lacking. The objective of this multicentre, randomised, double-blind controlled trial
was to compare the morphine-sparing effects of different combinations of three
NOAs-paracetamol (P), nefopam (N), and ketoprofen (K)-for postoperative
analgesia.
METHODS: Patients from 10 hospitals were randomised to one of eight groups:
control (C) received saline as placebo, P, N, K, PN, PK, NK, and PNK. Treatments
were given intravenously four times a day during the first 48 h after surgery, and
morphine patient-controlled analgesia was used as rescue analgesia. The outcome
measures were morphine consumption, pain scores, and morphine-related side-
effects evaluated 24 and 48 h after surgery.
RESULTS: Two hundred and thirty-seven patients undergoing a major surgical
procedure were included between July 2013 and November 2016. Despite a failure
to reach a calculated sample size, 24 h morphine consumption [median (inter-
quartile range)] was significantly reduced in the PNK group [5 (1-11) mg]
compared with either the C group [27 (11-42) mg; P<0.05] or the N group [21
(12-29) mg; P<0.05]. Results were similar 48 h after surgery. Patients experienced
less pain in the PNK group compared with the C, N, and P groups. No difference
was observed in the incidence of morphine-related side-effects.
CONCLUSIONS: Combining three NOAs with morphine allows a significant
morphine sparing for 48 h after surgery associated with superior analgesia the first
24 h when compared with morphine alone.
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